Leading Element Driving Change in the RNA Sequencing Services Market in 2025: Personalized Medicine Drives RNA Sequencing Market Growth Driver

What industry-specific factors are fueling the growth of the rna sequencing services market?
Significant growth in the RNA sequencing services market is largely attributed to the rising demand for personalized medicine. Personalized medicine is a method of customizing medical treatments based on individual variables such as genetics or lifestyle, with a goal to maximize efficacy and minimize possible side effects. This increasing demand for customized medical treatment is influenced by its ability to deliver more efficient solutions, advancements in the field of genomics, growing complexity of diseases, and policies in support. RNA sequencing services offer assistance in distinguishing different disease subtypes, discovering biomarkers, identifying possible therapeutic targets, predicting responses to therapy, and monitoring disease developments and the outcomes of treatment. Techniques in personalized medicine utilize RNA sequencing technologies to create personalized, effective medicines that address the molecular characteristics of each patient. For example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that the FDA (Food and Drug Administration) approved 16 new personalized therapies in 2023 for patients suffering from rare diseases, up from six approvals in 2022. The novel personalized treatments approved in 2023 also included seven cancer drugs and three for other diseases and conditions. Hence, the heightened demand for personalized medicine continues to drive the growth of the RNA sequencing services market.

Get Your RNA Sequencing Services Market Report Here:
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

What Is the projected market size and growth rate for the rna sequencing services market?
In recent years, the RNA sequencing services market has seen substantial growth. Its size is projected to increase from $3.58 billion in 2024 to $4 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The uptick in growth during the historical period can be linked to several factors, including a surge in demand for personalized medicine, the evolution of bioinformatics tools, an intensified focus on drug discovery and development, more significant usage of RNA sequencing in agricultural research, and broader applications in clinical diagnostics.

Expectations are high for the RNA sequencing services market, as it is predicted to experience a robust expansion over the coming years. By 2029, it is believed the market will hit $6.13 billion, with a compound annual growth rate (CAGR) of 11.3%. The projected surge during this period is largely due to the advent of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning in the interpretation of data, an increase in research into non-coding RNA biomarkers, a rising requirement for transcriptomic scrutiny in immunotherapy studies, and enhanced partnerships between academic and industrial sectors in genomic research. Key trends to watch for in this period are the adoption of long-read sequencing, the emergence of cloud-based analysis platforms, growing demand for RNA splicing analysis, and the integration of multi-omics data.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What new trends are reshaping the rna sequencing services market and its opportunities?
Leading firms in the RNA sequencing services market, such as Tempus, are leveraging automation to trim down potential manual errors and maximize efficiency and precision in data generation and analytical processes like next-generation sequencing (NGS) assays. The RNA-seq assay, a high-performing tool in molecular biology and genomics, facilitates comprehensive analysis of a biological sample's transcriptome. Consequently, Tempus, a US-based company specializing in precision medicine technology, revealed its novel standalone RNA next-generation sequencing assay, Tempus xR, in June 2023. This groundbreaking assay targets solid tumors and provides a thorough examination of the entire transcriptome, spotlighting clinically relevant fusions in more than 100 targeted genes, coupled with changed splicing for MET Exon 14 and EGFRvIII. Understanding the value of RNA sequencing records, Tempus has traditionally included both RNA and DNA sequencing in its typical xT broad-panel assay. Presently, customers can freely order individual tests or pair them, while enhancing xR with certain Tempus algorithmic tests as per preference. This product caters to physicians keen on RNA fusions or altered splicing, besides providers, researchers, and biopharmaceutical corporations in need of in-depth RNA sequencing evaluation for their existing samples.

What major market segments define the scope and growth of the rna sequencing services market?
The RNA sequencing services market covered in this report is segmented -

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods
3) By Application Area: Research Purposes, Diagnostic Purposes
4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion
2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing
3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the rna sequencing services industry growth?
Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

What Is Covered In The RNA Sequencing Services Global Market Report?

•Market Size Forecast: Examine the rna sequencing services market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the rna sequencing services market for a structured understanding.
•Key Players Overview: Analyze major players in the rna sequencing services market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the rna sequencing services market.
•Segment Contributions: Evaluate how different segments drive overall growth in the rna sequencing services market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the rna sequencing services market.
•Industry Challenges: Identify potential risks and obstacles affecting the rna sequencing services market.
•Competitive Landscape: Review strategic developments in the rna sequencing services market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.